Extraordinary science deserves to get paid.

Tandem is a specialized billing and appeals team focused solely on molecular oncology and precision diagnostic labs. Unique assays require unique billing.

  • We ride alongside your team
  • We surface denial patterns
  • We flag important payer insights
  • We spot missing information
  • We inform your commercialization strategy
  • We understand your science
  • We map recurring patterns
  • We catch underpayments
  • We untangle the complicated ones

The problem

Traditional billing is built for routine tests. Your assay isn't routine.

Standard billing workflows are designed for high volumes of low-value claims. Novel molecular tests break that model.

New tests. No playbook.

Your test may be billed under an unlisted code or its own PLA code, coverage is still being decided, and there's no payment history to lean on. Each claim carries real value, but it doesn't fit a standard workflow, so it's too often left behind.

The information gap

Payers ask for clinical details your lab never sees, like diagnosis history, prior treatments, and why the test was ordered. That information lives in the ordering physician's records, not yours. So claims get denied for reasons that have nothing to do with your test, your science, or the patient's need.

Small teams. Too much left unworked.

Early-stage labs run lean. When denials pile up unworked, they pass their deadlines and the revenue is lost, along with what each denial could have taught you about how payers see your test.

  1. Proprietary tumor profiling panel DeniedMedical necessity questioned We connect your science and each patient's clinical story to prove medical necessity.
  2. Liquid biopsy AgingNo payment recorded We follow up on unworked claims before their deadlines pass.
  3. Novel early-detection test DeniedAuthorization-related issue We flag authorization requirements before the claim goes out, and pursue retro-authorization or appeal where the payer allows it.
  4. MRD monitoring DeniedCoverage or testing-frequency restriction We check whether the patient met the payer's criteria, appeal when they did, and report the pattern.
Every claim deserves a closer look. Illustrative scenarios. Coverage and claim outcomes vary by payer and test.

How we ride

Appeals first.
People on every claim.

We connect your science with each patient's clinical story, claim by claim, building the strongest case for payment on every claim worth fighting.

  1. Learn your test

    Before your first claim goes out, we learn your assay: its codes, its evidence, the patients it's for, and what each payer is likely to ask for.

  2. Check before it's sent

    Every order goes through insurance verification and prior authorization checks before the claim is submitted. When something's missing, our team follows up, so fixable problems don't turn into denials.

  3. Sort every denial

    We review each denial as it arrives, find out why it happened, decide which are worth fighting, and start before deadlines pass.

  4. Chase the story, build the case

    We contact the ordering physician's office, collect the patient's records, and pair that clinical story with your assay's science in a complete appeal. Your team doesn't chase paperwork.

  5. Carry the lessons forward

    Every outcome shapes how we handle the next claim and comes back to you as reporting, so fewer claims get denied and your reimbursement pathway gets stronger.

HIPAA-compliant. Patient data is handled securely under a signed business associate agreement.

Billing that informs strategy

Turn every denial into insight.

Your claims show how payers see your test. We make sure your reimbursement, sales, and leadership teams can act on it.

01 / Reimbursement pathway

Learn from every claim.

Denials reveal documentation gaps, payer expectations, and where coverage is getting stuck. They also show which ordering practices send incomplete orders, so your sales team knows exactly where physician education will pay off.

02 / Payer history

Build a clean record from the start.

Every claim becomes part of how a payer sees your lab and your test. That history can come up in coverage reviews and audits. Consistent coding and complete documentation build a record that supports your case, rather than one that works against you.

03 / Insight you can use

Reporting built for your whole team.

We report what's being paid, what's being denied and why, and what's been recovered, broken out by payer and indication. Use it in coverage discussions, payer conversations, and board updates.

Why Tandem

  1. Revenue cycle management
  2. without going at it alone
  3. Work in tandem.

Promising diagnostics should never fail because reimbursement lags behind. We want life-changing diagnostics to reach the patients who need them. We help you get there.

Our story

Tandem was founded by a former molecular lab technologist turned LIS builder. After years of watching promising diagnostics labs struggle to get paid, too small for big billing vendors to prioritize, we built the hands-on partner they were missing.

Who it's for

Built for labs bringing a new molecular test to market.

  • You developed your own molecular test, in oncology or precision diagnostic testing, and run it in your own lab.
  • Payers are still catching up. Your test bills under an unlisted or PLA code, and coverage isn't settled yet.
  • You're starting to bill insurers, or your volume is growing faster than your team.
  • No one owns billing full-time, or your current biller doesn't know your test.
  • You suspect money is sitting in old denials, or in claims you've been holding.

Running routine tests with established codes and settled coverage? A high-volume billing vendor is probably a better fit.

Start a conversation

Built for where you are today. Let's talk.

Tell us a little about your lab and what's piling up. No pitch deck, no pressure.

Now talking with our first lab partners

We'll only use your details to get back to you.

Thanks. We'll be in touch soon.